Lv5
968 积分 2024-07-18 加入
Identification of a suitable and selective inhibitor towards aldehyde oxidase catalyzed reactions
9小时前
已完结
Endotoxin Limits in Formulations for Preclinical Research
3个月前
已完结
Tumor-derived IFN triggers chronic pathway agonism and sensitivity to ADAR loss
3个月前
已完结
Cancer cells resistant to immune checkpoint blockade acquire interferon-associated epigenetic memory to sustain T cell dysfunction
3个月前
已完结
Discovery of Kinesin KIF18A Inhibitor ATX020: Tactical Application of Silicon Atom Replacement
4个月前
已完结
A neomorphic protein interface catalyzes covalent inhibition of RAS G12D aspartic acid in tumors
4个月前
已完结
Discovery of Elironrasib (RMC-6291), a Potent and Orally Bioavailable, RAS(ON) G12C-Selective, Covalent Tricomplex Inhibitor for the Treatment of Patients with RAS G12C-Addicted Cancers
4个月前
已完结
Discovery of Daraxonrasib (RMC-6236), a Potent and Orally Bioavailable RAS(ON) Multi-selective, Noncovalent Tri-complex Inhibitor for the Treatment of Patients with Multiple RAS-Addicted Cancers
4个月前
已完结
A patent review of CYP3A4 inhibitors (2018 - present)
4个月前
已完结
Preclinical models of prostate cancer — modelling androgen dependency and castration resistance in vitro, ex vivo and in vivo
4个月前
已完结
皖公网安备34019202002308
